Creative Planning Novavax Inc Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Novavax Inc stock. As of the latest transaction made, Creative Planning holds 32,482 shares of NVAX stock, worth $303,706. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,482

Previous 24,143 34.54%

Holding current value

$303,706

Previous $305,000 34.43%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$10.71 - $17.11 $89,310 - $142,680	8,339 Added 34.54%	32,482 $410,000
Q2 2024 Aug 15, 2024	BUY	$3.89 - $20.97 $10,471 - $56,451	2,692 Added 12.55%	24,143 $305,000
Q1 2024 May 10, 2024	BUY	$3.76 - $6.02 $8,614 - $13,791	2,291 Added 11.96%	21,451 $102,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $91,968 - $146,957	19,160 New	19,160 $91,000
Q2 2023 Jul 21, 2023	BUY	$6.67 - $9.52 $133,113 - $189,990	19,957 Added 159.1%	32,501 $241,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $9,388 - $20,342	1,630 Added 14.93%	12,544 $86,000
Q4 2022 Feb 10, 2023	SELL	$8.86 - $25.04 $28,777 - $81,329	-3,248 Reduced 22.93%	10,914 $112,000
Q3 2022 Nov 03, 2022	BUY	$18.2 - $76.12 $71,052 - $297,172	3,904 Added 38.06%	14,162 $258,000
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $38,638 - $80,183	1,065 Added 11.58%	10,258 $528,000
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $117,355 - $240,500	1,683 Added 22.41%	9,193 $677,000
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $7,400 - $11,988	-55 Reduced 0.73%	7,510 $1.07 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $7,289 - $11,093	41 Added 0.54%	7,565 $1.57 Million
Q2 2021 Aug 04, 2021	SELL	$121.0 - $257.67 $17.3 Million - $36.8 Million	-142,896 Reduced 95.0%	7,524 $1.6 Million
Q1 2021 Apr 30, 2021	SELL	$112.98 - $319.93 $438,475 - $1.24 Million	-3,881 Reduced 2.52%	150,420 $27.3 Million
Q4 2020 Jan 29, 2021	BUY	$78.74 - $139.5 $2.08 Million - $3.68 Million	26,385 Added 20.63%	154,301 $17.2 Million
Q3 2020 Nov 05, 2020	BUY	$79.44 - $178.51 $2.75 Million - $6.18 Million	34,608 Added 37.09%	127,916 $13.9 Million
Q2 2020 Jul 23, 2020	BUY	$13.86 - $83.61 $220,872 - $1.33 Million	15,936 Added 20.6%	93,308 $7.78 Million
Q1 2020 May 05, 2020	BUY	$3.93 - $16.0 $150,251 - $611,712	38,232 Added 97.68%	77,372 $1.05 Million
Q4 2019 Jan 30, 2020	SELL	$3.69 - $5.22 $196,322 - $277,724	-53,204 Reduced 57.62%	39,140 $156,000
Q3 2019 Nov 01, 2019	BUY	$4.02 - $7.84 $52,666 - $102,711	13,101 Added 16.53%	92,344 $464,000
Q2 2019 Jul 26, 2019	BUY	$4.93 - $12.2 $390,667 - $966,764	79,243 New	79,243 $464,000

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

84.8M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Novavax Inc Transaction History